825619-29-2

• 常用中文名：1H-Benzimidazole, 6-(4-Morpholinylmethyl)-2-(4-nitro-1H-pyrazol-3-yl)-
• 常用英文名：1H-Benzimidazole, 6-(4-Morpholinylmethyl)-2-(4-nitro-1H-pyrazol-3-yl)-
• CAS号：825619-29-2
• 分子式：C₁₅H₁₆N₆O₃
• 分子量：328.32600
• 发布时间：2017-05-03 10:37:09
• 更新时间：2024-01-10 14:05:14

名称

• 英文名: 4-[[2-(4-nitro-1,2-dihydropyrazol-3-ylidene)benzimidazol-5-yl]methyl]morpholine

物化性质

• 分子式: C₁₅H₁₆N₆O₃
• 分子量: 328.32600
• 精确质量: 328.12800
• PSA: 115.65000
• LogP: 2.15450

合成路线

825619-02-1 5334-40-7 ~59% 825619-29-2

文献：ASTEX THERAPEUTICS LIMITED Patent: WO2007/77435 A1, 2007 ; Location in patent: Page/Page column 205 ; WO 2007/077435 A1

825619-03-2 ~% 825619-29-2

文献：Zheng, Youguang; Zheng, Ming; Ling, Xin; Liu, Yi; Xue, Yunsheng; An, Lin; Gu, Ning; Jin, Min Bioorganic and Medicinal Chemistry Letters, 2013 , vol. 23, # 12 p. 3523 - 3530

528-45-0 ~% 825619-29-2

文献：Zheng, Youguang; Zheng, Ming; Ling, Xin; Liu, Yi; Xue, Yunsheng; An, Lin; Gu, Ning; Jin, Min Bioorganic and Medicinal Chemistry Letters, 2013 , vol. 23, # 12 p. 3523 - 3530

24376-18-9 ~% 825619-29-2

文献：Zheng, Youguang; Zheng, Ming; Ling, Xin; Liu, Yi; Xue, Yunsheng; An, Lin; Gu, Ning; Jin, Min Bioorganic and Medicinal Chemistry Letters, 2013 , vol. 23, # 12 p. 3523 - 3530

65003-28-3 ~% 825619-29-2

文献：Zheng, Youguang; Zheng, Ming; Ling, Xin; Liu, Yi; Xue, Yunsheng; An, Lin; Gu, Ning; Jin, Min Bioorganic and Medicinal Chemistry Letters, 2013 , vol. 23, # 12 p. 3523 - 3530